Cliropamine (INNTooltip International Nonproprietary Name; developmental code name D-16427) is a positive inotropic drug of the phenethylamine and amphetamine families which was never marketed.[1][2][3][4] It was first described by 1986.[4]

References

  1. ^ Negwer M, Scharnow HG (2001). Organic-chemical Drugs and Their Synonyms: An International Survey. Wiley-VCH. p. 1802. ISBN 978-3-527-30247-5. Retrieved 27 February 2025. Cliropamine hydrochlo- ride ** , D - 16427 U Cardiotonic ( positive inotropic ) 8879 ( 7264 ) C19H25NO2 CH, 2- [Propyl(2-thienylethyl)amino]-5-hydroxytetralin-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl) ethyl] [...]
  2. ^ "CLIROPAMINE". Inxight Drugs. Retrieved 27 February 2025.
  3. ^ "The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances" (PDF). World Health Organization. Geneva. 2004.
  4. ^ a b Engel J, Bickel E, Klingler KH, Schönenberger H (December 1986). "[14C-labeling of D 16,427, a new positive inotropic agent]". Arch Pharm (Weinheim) (in German). 319 (12): 1113–1116. doi:10.1002/ardp.19863191210. PMID 2882738.



No tags for this post.